Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(742)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Jan 31, 2022 10:23am
Key words...
'Potently nuetralizes...all variants of concern" Next Up... FDA..must fast track those human Trials...before they dot another "i" The beauty of this play.? The CRO
...more
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Comment by
Betteryear2
on Jan 31, 2022 7:20am
RE:Neutralizes the SARS-CoV-2 Omicron Variant
Title is the following: Immunotherapeutic PolyTope® from ImmunoPrecise (IPA) Potently Neutralizes the SARS-CoV-2 Omicron Variant – Moves Towards FDA/IND-Submission
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 31, 2022 7:17am
Neutralizes the SARS-CoV-2 Omicron Variant
During in vitro pseudovirus assays, IPA's PolyTope® advanced immunotherapeutic TATX-03 prevents infection of cells by SARS-CoV-2 variant-of-concern, Omicron, and all variants of
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Jan 25, 2022 9:52pm
Bath time for ipa.
Did you see the fda release.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jan 25, 2022 4:00pm
RE:Buy list - with a nice summary as to why.
What IPA has is gold. They rose to great heights during the peak of Covid and fell hard. However their tech keeps proving itself especially the potential of TATX. I'm adding more because I think
...more
(742)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Jan 18, 2022 9:34am
Buy list - with a nice summary as to why.
https://www.medicalgold.ca/posts/medicalgolds-canadian-insider-weekly-buy-list
(17)
•••
Vancgatekeeper
X
View Profile
View Bullboard History
Comment by
Vancgatekeeper
on Jan 13, 2022 7:39pm
RE:Oh yeah! Showing life again. Up we go
yep, def double digits next week, Chart is prime for massive breakout.. Company will be re rated soon :) 300-500 MIllion Cap IMO $$
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jan 13, 2022 12:16pm
Oh yeah! Showing life again. Up we go
Not sure why but I like the volume action. 2x vol on NAS than on TSX. We could be in dub digits soon.
(17)
•••
Vancgatekeeper
X
View Profile
View Bullboard History
Post by
Vancgatekeeper
on Jan 07, 2022 5:37pm
IPA closed over 20,50,100 MDAs this week!
200 mda around $9- once 200 mda clears GAME ON. 120 MIllion market cap is peanuts for nasdaq biotech with ipa growth . 3-5x coming 2022! BUCKLE UP COWBOYS!
(742)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Jan 07, 2022 4:51pm
Of interest to IPA investors...
There is growing evidence that Omicron may have evolved in an animal population (namely mice) before a human acquired the virus in SA. Omicron is such an outlier to the original strains up to and
...more
(17)
•••
Vancgatekeeper
X
View Profile
View Bullboard History
Comment by
Vancgatekeeper
on Jan 04, 2022 5:17pm
RE:Momentum seems to be building
116 MILLION CAP, en route to 500 :) 40 mill in bank- GAME ON 2022!
(17)
•••
Vancgatekeeper
X
View Profile
View Bullboard History
Comment by
Vancgatekeeper
on Jan 04, 2022 5:15pm
RE:Momentum seems to be building
buckle up Cowboy..wont be surprised to see 30-40 :) enjoy the ride!
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jan 04, 2022 2:55pm
Momentum seems to be building
I hope this leads to double digits soon.
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Jan 03, 2022 12:25pm
RE:RE:CEO JENNIFER BATH BUYS TODAY!
Looking strong on the Nasdaq this morning . up $ .32 US......was up $.41 US Something is brewing.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Growth Rocket 2025 – Why dynaCERT is in the Spotlight